Lilly Glucagon: Clinical Trials

5 trials of Lilly Glucagon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 2 Phase 2, 2 Phase 3, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2
Not applicable1Terminated 1
Phase 11Completed 1

Follow Lilly Glucagon: new trials by email Literature Review of Lilly Glucagon trials Research Report on Lilly Glucagon

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
G-Pen, Lilly Glucagon - Insulin Hypoglycemia, Type 1 Diabetes Mellitus
Phase 3CompletedXeris Pharmaceuticals812018-01-232020-02-17
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
ZP4207(dasiglucagon) glucagon analogue, Glucagon (Native glucagon) - Diabetes Mellitus Type 1
Phase 2CompletedZealand Pharma382016-12-012017-04-21
The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas
iPhone bionic pancreas, iLet bionic pancreas, Xeris Xerisol glucagon - Diabetes Mellitus Type 1
Not applicableTerminatedMassachusetts General Hospital202016-03-012019-11-18
Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons
BIOD-961, Lilly Glucagon, Novo Glucagon - Hypoglycemia
Phase 1CompletedBiodel152014-11-012016-01-15
Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
Xeris glucagon, Lilly glucagon - Type 1 Diabetes
Phase 2 / Phase 3CompletedSteven J. Russell, MD, PhD202014-04-012019-10-08

Conditions studied

Diabetes Mellitus, Type 1 (4)  ·  Hypoglycemia (2)  ·  Insulin Resistance (2)

Sponsors

Biodel (1)  ·  Massachusetts General Hospital (1)  ·  Steven J. Russell, MD, PhD (1)  ·  Xeris Pharmaceuticals (1)  ·  Zealand Pharma (1)

Countries

United States (3)  ·  Canada (1)  ·  Germany (1)

Top investigators

Steven J Russell, MD, PhD (2)  ·  Alan Krasner, MD (1)  ·  Linda Morrow, MD (1)

Results publications

PMID 34620618